The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Botanicals and Hepatotoxicity
Abstract
The use of botanicals, often in the form of multi‐ingredient herbal dietary supplements (HDS), has grown tremendously in the past three decades despite their unproven efficacy. This is paralleled by an increase in dietary supplement‐related health complications, notably hepatotoxicity. This article reviews the demographics and motivations of dietary supplement (DS) consumers and the regulatory framework for DS in the US and other developed countries. It examines in detail three groups of multi‐ingredient HDS associated with hepatotoxicity: OxyElite Pro (two formulations), green tea extract‐based DS, and “designer anabolic steroids.” These examples illustrate the difficulties in identifying and adjudicating causality of suspect compound(s) of multi‐ingredient HDS‐associated liver injury in the clinical setting. The article outlines future directions for further study of HDS‐associated hepatotoxicity as well as measures to safeguard the consumer against it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The 1994 Dietary Supplement Health and Education Act provides the current regulatory framework for supplement manufacturing and distribution in the United States.126”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Self-citationLiver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network
Navarro, V. J., Barnhart, H., Bonkovsky, H. L., Davern, T., Fontana, R. J., Grant, L., Reddy, R. K., Seeff, L. B., Serrano, J., Sherker, A. H., et al. (2014) · Hepatology · doi:10.1002/hep.27317 · Cited by 418 · cited 1×
“The study also found an overall increase in DILI cases attributable to HDS from 7–20% over the 10-year study period with a most significant increase in nonbodybuilding HDS cases (from 5% in 2004–2005 to 12% in 2010– 2012).(25) These findings not only point out the possibility of increasing use of nonbody-building HDS…”
Self-citationHazards of Hindsight — Monitoring the Safety of Nutritional Supplements
Cohen, P. A. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1315559 · Cited by 149
Acute hepatitis associated with the use of green tea infusions
Jimenez-Saenz, M., & Martinez-Sanchez, M. D. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.041 · Cited by 95
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern
Javaid, A., & Bonkovsky, H. L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.005 · Cited by 57
Research works printed but not linked: 67
- Wilkins J, 1995, Food in Antiquity
- Hippocrates, 1983, Hippocratic Writings
- 10.2307/148493 · doi:10.2307/148493
- 10.1093/acprof:oso/9780195331479.001.0001 · DOI · Paper page
- Pearson D., 1982, Life Extension: A Practical Scientific Approach
- 10.1001/jama.1983.03340200094043 · doi:10.1001/jama.1983.03340200094043
- 10.1002/hep.28813 · DOI · Paper page
- 10.1007/s40264-016-0428-7 · DOI
- 10.1177/003335491513000515 · DOI
- 10.1038/ajg.2014.159 · DOI
- 10.1016/j.cld.2013.07.006 · DOI
- 10.7205/MILMED-D-12-00265 · DOI
- 10.1002/pds.2180 · DOI
- 10.1038/ajg.2010.5 · DOI
- 10.1016/j.jhep.2007.06.016 · DOI
- 10.1002/dta.1980 · DOI
- Amin A., 2009, Overview of major classes of plant‐derived anticancer drugs, Int. J. Biomed. Sci., 5, 1, 10.59566/IJBS.2009.5001 · DOI
- 10.1016/j.biotechadv.2015.08.001 · DOI · Paper page
- 10.1053/j.gastro.2014.12.004 · DOI
- 10.1001/jamainternmed.2013.2299 · DOI · Paper page
- 10.1007/s40264-017-0547-9 · DOI · Paper page
- 10.1016/j.transproceed.2016.11.041 · DOI
- 10.1002/hep.29466 · DOI · Paper page
- 10.1080/07315724.2013.875423 · DOI · Paper page
- 10.1080/01639360802634043 · DOI
- 10.2165/11586490-000000000-00000 · DOI
- 10.3350/cmh.2012.18.3.249 · DOI · Paper page
- 10.1002/hep.26175 · DOI · Paper page
- 10.1002/hep.26709 · DOI · Paper page
- 10.1002/hep.510260319 · DOI · Paper page
- 10.1038/clpt.1981.154 · DOI · Paper page
- 10.1007/s10822-016-9972-6 · DOI
- 10.1016/0895-4356(93)90101-6 · DOI · Paper page
- 10.1002/hep.23577 · DOI · Paper page
- 10.1002/hep.22442 · DOI · Paper page
- 10.2165/00002018-200932010-00005 · DOI · Paper page
- 10.3390/ijms17020201 · DOI · Paper page
- 10.1111/1541-4337.12289 · DOI
- European Food Safety Authority, 2012, Compendium of botanicals reported to contain naturally occuring substances of possible concern for human health when used in food and food supplements, EFSA J
- 10.2903/j.efsa.2009.1249 · DOI · Paper page
- Lammie J. Report of the Department of Defense. 1 3 Dimethylamylamine (DMAA) Safety Review Panel. 2013; Available at: <https://www.opss.org/sites/default/files/Report-of-the-DoD-DMAA-Safety-Review-Panel-2013.pdf> Accessed 2/26/18.
- Armstrong M., 2012, Atrial fibrillation with rapid ventricular response following use of dietary supplement containing 1,3 dimethylamylamine and caffeine, J. Spec. Oper. Med., 12, 1, 10.55460/1MSW-PLTV · doi:10.55460/1msw-pltv
- 10.1016/j.annemergmed.2012.04.008 · doi:10.1016/j.annemergmed.2012.04.008
- Gee P., 2010, Another bitter pill: a case of toxicity from DMAA party pills, N. Z. Med. J., 123, 124
- Centers for Disease Control and Prevention, (CDC), 2013, Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building—May‐October 2013, MMWR Morb. Mortal. Wkly. Rep., 62, 817
- 10.1016/j.bmcl.2006.12.037 · DOI
- 10.1016/j.bmcl.2011.08.099 · doi:10.1016/j.bmcl.2011.08.099
- 10.2174/138920110791591535 · DOI
- 10.1016/S0168-8278(98)80056-1 · DOI · Paper page
- 10.1258/rsmmsl.44.3.252 · DOI
- 10.1016/0091-7435(92)90041-F · DOI · Paper page
- 10.7326/0003-4819-144-1-200601030-00020 · DOI · Paper page
- 10.1002/lt.21021 · DOI · Paper page
- 10.1097/00042737-200510000-00021 · DOI
- 10.1007/s10620-013-2687-9 · DOI
- 10.1016/j.fct.2014.11.008 · DOI
- 10.1111/apt.13023 · DOI · Paper page
- 10.1016/j.fct.2012.07.006 · DOI
- 10.1136/bmj.e468 · DOI
- 10.1097/MCG.0b013e31815a5796 · DOI
- 10.7326/0003-4819-159-7-201310010-00019 · DOI
- 10.1111/liv.12216 · DOI
- 10.3390/ijms18051018 · DOI · Paper page
- 10.1136/bcr-2015-210303 · DOI
- Sharma T., 2010, Hydroxycut(®) (herbal weight loss supplement) induced hepatotoxicity: a case report and review of literature, Hawaii Med. J., 69, 188
- 10.1016/j.jhep.2007.06.014 · DOI · Paper page
- 10.1007/s10620-016-4181-7 · DOI
Cited by
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citationTeschke, R. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1539077 · Cited by 24
Metadata
- Authors
- Roytman, M. M., Poerzgen, P., & Navarro, V.
- Affiliations
- University of California San Francisco Fresno California USA
- Fresno California USA
- Einstein Medical Center Philadelphia Pennsylvania USA
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2018-06-19
- Volume
- 104
- Issue
- 3
- Pages
- 458-469
- ISSN
- 0009-9236
- 1532-6535
- Cited by
- 30
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Botanicals and Hepatotoxicity. https://app.cochat.ai/papers/10.1002/cpt.1097
- The paper
- Roytman, M. M., Poerzgen, P., & Navarro, V. (2018). Botanicals and Hepatotoxicity. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.1097
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.